Chinese researchers develop immunotherapeutic agent for colon cancer
Time:2024-05-07 15:30:38 Source:politicsViews(143)
TIANJIN, March 15 (Xinhua) -- Chinese researchers have developed a novel immunotherapeutic agent for treating colon cancer, according to a recent article in the academic journal ACS Nano. In animal experiments, the agent, upon successful entry into tumor cells, can enhance T cell effector function to kill tumor cells and suppress colon tumor growth, according to Lu Chunwan from the School of Life Sciences of Tianjin University, one of the authors of the article. The agent can enhance tumor immunogenicity and inhibit colon tumor growth, with no significant impact on normal cells, said Lu. Colon cancer, characterized by its long latency period and high mortality rate, poses a severe threat to human health. Among various therapies, immunotherapy is considered one of the most promising treatment directions, according to Lu.
(Editor:Fu Bo)
share to:
Kind tips:The above content and pictures are compiled from the Internet and are for reference only. I hope they will be helpful to you! If there is any infringement, please contact us to delete it.!
You may also like
- I have the largest penis in Britain
- Maglev train with a speed of 600 kilometers per hour debuted at the World Manufacturing Conference
- Travel industry posts solid recovery during Spring Festival
- Economy on stable footing, experts say
- Nigerian journalist's arrest last week triggers criticism of worsening press freedoms
- Chinese commerce minister meets with WTO director
- Images: 2023 World Internet of Things Exposition
- Chinese firms rush to obtain global orders: experts
- Judges ask whether lawmakers could draw up new House map in time for this year's elections